IRE: Fintech Transformer - From Conglomerate Chaos to Software Success
HOLD rating with $6.03 fair value vs $7.96 current price. Strong business quality (8.04/10) but overvalued with 24% downside risk despite transformation success.
View noteHOLD rating with $6.03 fair value vs $7.96 current price. Strong business quality (8.04/10) but overvalued with 24% downside risk despite transformation success.
View noteIPH trades at $4.78 vs fair value $9.29 (94% upside). Market leader with 29.3% Australian share, CIPO recovery catalyst, 32% EBITDA margin target.
View noteIVE Group trades at $2.99 vs fair value $8.19, offering 174% upside through portfolio transformation from print to packaging/logistics. Market leader with strong execution track record.
View noteHOLD rating with $3.61 fair value vs $4.27 current price. Exceptional ROIC 71.6% offset by cyclical peak timing concerns and inevitable margin compression.
View noteTrading at $2.94 vs $6.91 fair value (135% upside). Strong balance sheet, 48% recurring revenue, 23.1% ROIC. Cyclical normalisation expected.
View noteFreightways trades at NZ$10.22 versus NZ$20.85 fair value (104% upside). Market-leading logistics provider with 19.8% EBITDA margins, 14.2% ROIC, and demonstrated pricing power trading at 47% discount to peers.
View noteFortescue trades at A$19.84 versus fair value A$26.47 (33% upside), with 2.4x EV/EBITDA at 41% discount to peers despite industry-leading C1 costs US$17.99/wmt and 0.14x net debt-to-EBITDA.
View noteBUY rating with $17.07 fair value vs $12.38 current price. Strong Australian market position, successful operational transformation, 38% upside potential over 18-24 months.
View noteFair value $0.84 vs current $0.72. 22% EBITDA margins, 72% government funding, 13% revenue growth. Consolidation platform in fragmented market.
View noteHOLD rating with $28.34 fair value vs $27.04 current price. Market leader in independent trustee services with 8.3% FCF yield, though regulatory overhang and fee compression limit upside.
View notePayment processor trading at 42% discount to peers. Fair value $1.60 vs current $1.07. EBITDA margins recovering from 16.5% toward 26% through transformation programme.
View noteBUY rating with $1.83 fair value vs $0.93 current price. 38.3% EBITDA margins, 18.5% market share, trading at 63% discount to peers despite superior metrics.
View note